
Prostate
HealthNew drug combo cuts risk of death for men with prostate cancer by 40%
A drug combo of enzalutamide and leuprolide cuts death risk by 40% for men with recurrent prostate cancer.
Joseph Shavit

A drug combo of enzalutamide and leuprolide cuts death risk by 40% for men with recurrent prostate cancer.
Joseph Shavit
